For the latest targeted drugs for cervical cancer, PD-L1 and bevacizumab are more frequently used in clinical practice, often combined with chemotherapy drugs, such as carboplatin and paclitaxel, which can play a better role in post-operative treatment. However, it must be noted that during the drug administration period, not only the diet must be strengthened, but also the specific treatment must be given according to the targeted drug regimen formulated by the doctor, which may cause serious gastrointestinal reactions and hair loss and other corresponding symptoms. In addition, patients with cervical cancer must be reviewed regularly according to the doctor’s prescriptions and abnormal problems should be treated in time.